Findings showed the hazard ratio for OS compared with busulfan was 0.67 in all randomized patients. The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback